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b s t r a c t
The cytokine IL-1 is critical to the pathogenesis of a variety of human conditions and diseases. Unlike most other cytokines, IL-1 is counterbalanced by two endogenous inhibitors. The functional significance of IL-1 receptor antagonist (IL-1RA) is well documented due to the clinical utilization of the recombinant human IL-1RA analog, anakinra. In contrast, much less is known about the type 2 IL-1 receptor (IL-1R2), which acts as a decoy receptor for IL-1. While IL-1R2 is structurally similar to the type 1 IL-1 receptor (IL-1R1) responsible for IL-1 signal transduction, its truncated cytoplasmic domain and lack of Toll-IL-1 receptor (TIR) region renders IL-1R2 incapable of transmembrane signaling. IL-1R2 competes with IL-1R1 for ligands and for the IL-1R1 co-receptor, IL-1 receptor accessory protein (IL-1RAP). Additionally, IL-1R2 exists in both a membrane bound and soluble form (sIL-1R2) that has biological properties similar to both a decoy receptor and a binding protein. Thus far, IL-1R2 has been implicated in arthritis, endometriosis, organ transplantation, sepsis/sickness behavior, diabetes, atherosclerosis, autoimmune inner ear disease (AIED), Alzheimer's disease and ulcerative colitis. In this review, we will detail the functional properties of IL-1R2 and examine its role in human disease.
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Introduction
The IL-1 system includes an interesting array of at least 21 distinct molecules encompassing receptors, co-receptors, ligands, and endogenous antagonists (Dinarello, 2009) . IL-1a and IL-1b (collectively referred to as IL-1) serve as soluble and principally extracellular activators of the IL-1 system, whereas IL-1 receptor antagonist (IL-1RA) is a competitive inhibitor that prevents IL-1a and IL-1b from interacting with the IL-1 receptor 1 (IL-1R1). IL-1R1, in turn, associates with IL-1 receptor accessory protein (IL-1RAP) to create a transmembrane signaling complex that initiates IL-1-dependent intracellular signaling (Korherr et al., 1997) . Somewhat unique to the IL-1 system is the existence of two distinct types of IL-1Rs, namely IL-1R1 and the type 2 IL-1 receptor (IL-1R2). IL-1R1, as noted above, is responsible for IL-1 signal transduction. IL-1R2 serves as an endogenous inhibitor of IL-1 signaling (Fig. 1) . IL-1R2 was first characterized by McMahan et al. (1991) and is considered the prototypical decoy receptor. More recently, analogous decoy receptors have been identified for IL-18 and TNF (Mantovani et al., 2001) . The purpose of these non-signaling receptors is still somewhat unclear, but functionally, they serve as important negative regulators.
The IL-1 pathway regulates inflammation, angiogenesis, hematopoiesis and cognition (Rachal Pugh et al., 2001; Shieh et al., 1991) . As the first interleukin to be characterized, IL-1 was initially termed endogenous pyrogen for its ability to produce fever in animals and humans. Subsequent work demonstrated the importance of IL-1 to a variety of sickness behaviors, including anorexia, lethargy, locomotion and social exploration (Dantzer, 2001) . Confirming the mechanistic importance of IL-1 to sickness were experiments demonstrating that IL-1 antagonism mitigates LPSdependent reductions in social exploration and food-motivated behavior in mice (Bluthe et al., 1992; Kent et al., 1992; Laye et al., 2000) . Overall, much of what is known about IL-1 bioaction is derived from work using IL-1 and IL-1R1 knock out (KO) mice or administered IL-1RA. Given the near absence of IL-1R2 mouse models and IL-1R2 recombinant/synthetic molecules/analogs, the functional role of IL-1R2 is often extrapolated from work with 0889-1591/$ -see front matter Ó 2012 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.bbi.2012.11.006
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